Hvilken er prisen på PharmaSGP Holding SE (PSG)

Prisen på PharmaSGP Holding SE (PSG) er $34.40

Hva er markedsverdien på PharmaSGP Holding SE (PSG)

Markedsverdien på PharmaSGP Holding SE (PSG) er $396.01M

PharmaSGP Holding SE (PSG) Prishistorikk

Founded in 2012 and based in Gräfelfing, Germany, PharmaSGP Holding SE specializes in the production of over-the-counter (OTC) pharmaceuticals and diverse healthcare goods. The company offers an extensive portfolio of products addressing various health concerns. This includes Baldriparan for sleep disturbances; pain relief solutions like Spalt, Formigran, and Kamol massage cream; RubaXX, specifically designed for rheumatic pain in bones, tendons, and muscles; and Restaxil, which targets nerve pain in the neck and back. Furthermore, their offerings encompass Fulminan, a beauty beverage for areas such as the eyes, buttocks, and thighs; DESEO drops for sexual weakness; Neradin, a medication for sexual dysfunction; and TAUMEA, aimed at managing vertigo. PharmaSGP also develops treatments for chronic conditions, including persistent pain and other age-associated ailments. Its products reach consumers via pharmacies and wholesalers, and are exported to several European nations, including Austria, Italy, Belgium, Spain, and France.

År	Ytelse
2025	32.25%
2024	15.81%
2023	-19.38%
2022	-0.56%
2021	-2.10%
2020	349.83%
2011	0.00%

År

Ytelse

2025

32.25%

2024

15.81%

2023

-19.38%

2022

-0.56%

2021

-2.10%

2020

349.83%

2011

0.00%

Selskap	Aksjepris	Endring 1år%	Land
MERCK Kommanditgesellschaft auf Aktien MER.SW	$171.67	-	DE
Merck KGaA MRK.DE	$167.72	31.75%	DE
Takeda Pharmaceutical Company Limited 4502.T	$38.30	26.13%	JP
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	$21.25	19.61%	IN
Galderma Group AG GALD.SW	$214.79	22.87%	CH

Selskap

Aksjepris

Endring 1år%

Land